ITGAM and neoplasm: We also found that even though tumor sizes were smaller with anti-CD11b antibody treatment, the tumor doubling time remained the same from days 14–21, suggesting that once tumors were established, the growth of tumor cells was not inhibited by CD11b+ cell depletion (Supplemental Figure 7).